Health ❯ Healthcare ❯ Public Health ❯ Infectious Diseases

HIV/AIDS

France Authorizes Fully Reimbursed Apretude, a Long-Acting HIV PrEP Injection

Full coverage follows lengthy price negotiations, highlighting unresolved limits on who can receive it.

World AIDS Day 2025: Latin America’s HIV Cases Rise as Testing Expands and Long-Acting Drugs Win Approval

Conitec Begins Review of Injectable HIV PrEP for Brazil's SUS

Monthly Oral PrEP Candidate MK-8527 Shows Early Promise in Merck Study

FDA Approves Twice-Yearly Lenacapavir Injection for HIV Prevention

Judge Allows Trump Administration to Continue Overhaul of USAID

Lenacapavir Injection Offers Breakthrough in HIV Prevention

Global HIV Infections and Deaths Reach Historic Lows, UNAIDS Warns Progress Too Slow

Lenacapavir Injection Shows 96% Efficacy in Preventing HIV